COVID-19 VLP (M; N; S; E Proteins)(CBS-V953)
Inquiry
| Product Summary | |
|---|---|
| Name | COVID-19 VLP (M; N; S; E Proteins) |
|
|
|
| Cat No. | CBS-V953 |
| Source | Insect cell recombinant |
| Virus Name | SARS-CoV-2 |
| Virus Family | Coronaviridae |
| Composition | Spike (S), envelope (E), nucleocapsid (N, 6His-tagged) and membrane (M) proteins |
| Purity | 85% |
| Presentation | 20mM Tris-Cl, pH7.9, 100mM NaCl and 0.5mM EDTA. |
| Description | Recombinant SARS-CoV-2 VLP that comprising Spike (S), envelope (E), nucleocapsid (N, 6His-tagged) and membrane (M) proteins was expressed from insect cells.The VLPs were purified by a combination of gradient centrifugation and chromatographic methods. |
For Research or Industrial Raw Materials, Not for Personal Use!
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Frequently Asked Questions
-
What expression systems do you use for your VLP products?
Our virus-like particles are produced from different expression systems such as E. coli, yeast, insect cells, and HEK293 cells.